Viral Hepatitis

• CLINICAL_TRIALS trial_result · 2007-11-20
  Clinical Trial Update: Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 4]

  Phase 4 clinical trial update evaluating the weight-loss drug Orlistat (Xenical) for overweight patients with nonalcoholic steatohepatitis (…

• FDA approval · 2007-06-19
  FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)

  FDA approved a supplemental application for PEGASYS (peginterferon alfa-2a) submitted by pharmaand GmbH.

• FDA approval · 2007-05-21
  FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)

  FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) to update its labeling.

• FDA approval · 2006-12-22
  FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)

  The FDA approved a supplemental application for EMTRIVA (emtricitabine) from Gilead Sciences.

• FDA approval · 2006-10-25
  FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)

  FDA approved a supplemental application for Epivir (lamivudine) submitted by ViiV Healthcare Company.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-10-25
  FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)

  FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company. This action confirms regulatory approv…

• EMA safety_alert · 2006-07-18
  EMEA Public Statement on herbal medicinal products containing cimicifugae racemosae rhizoma - Serious hepatic reactions

  EMA warns that herbal medicinal products containing cimicifugae racemosae rhizoma (black cohosh) have been associated with serious hepatic r…

• FDA approval · 2006-06-13
  FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)

  FDA approved a supplemental application for Epivir (lamivudine) submitted by ViiV Healthcare Company. This action represents a supplemental …